Latest Breaking News On - Refractory diabetic - Page 1 : comparemela.com

Provides Favorable Access to a New $500 Million Market for the Treatment of Refractory Diabetic and Venous Ulcers for EPIFIX – the First and Only Amniotic.

Hilary dixonJack howarthTakanori kuramotoHiroto terashiRohit kashyapJapanese ministry of healthJapan society for surgical wound careJapanese society for foot careMimedx group incCorporate strategic communicationsDepartment of plastic surgery at kobe universityProvides favorable accessRefractory diabeticVenous ulcersOnly amniotic tissue product approvedMedx group